Financhill
Back

Plus Therapeutics Stock Predictions

Plus Therapeutics Stock Forecast

  • Is Plus Therapeutics Stock Undervalued?
    The current Plus Therapeutics [PSTV] share price is $1.09. The Score for PSTV is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • PSTV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Plus Therapeutics Stock Go Up Next Year?

Data Unavailable

Plus Therapeutics Stock Rating

Data Unavailable

Plus Therapeutics Stock Price History

Is PSTV stock going to rise?

  • The current trend is relatively stagnant and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
plustherapeutics.com

52-Week Data

52-Week High:
2.67
52-Week Low:
0.93

Prediction Charts

Market Cap:
6.4M
Price in USD:
1.09
Volume:
49K
Beta:
1.29

Technical Analysis

SMA50:
1.29
SMA100:
1.38
SMA200:
1.63
52-Wk Change:
-41.4%

Stock Predictions

  • Is Plus Therapeutics stock public?
    Yes, Plus Therapeutics is a publicly traded company.
  • What is the Plus Therapeutics stock quote today?
    The Plus Therapeutics stock price is 1.09 USD today.
  • How to buy Plus Therapeutics stock online?
    You can buy Plus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 1.30 1.34 1.42 1.30
Dec-4 1.33 1.33 1.37 1.32
Dec-5 1.36 1.34 1.40 1.31
Dec-6 1.38 1.39 1.45 1.32
Dec-9 1.38 1.35 1.41 1.33
Dec-10 1.34 1.31 1.36 1.30
Dec-11 1.36 1.35 1.36 1.30
Dec-12 1.36 1.33 1.37 1.26
Dec-13 1.31 1.27 1.33 1.22
Dec-16 1.28 1.17 1.28 1.12
Dec-17 1.21 1.07 1.23 1.03
Dec-18 1.07 1.00 1.10 0.98
Dec-19 1.01 0.99 1.10 0.93
Dec-20 1.01 1.09 1.11 0.97

Plus Therapeutics Earnings

Data Unavailable

Plus Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.80 per share, and a decrease next year of $0.04 per share.

* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.